Alterity Therapeutics Ltd (ATHE)

Alterity Therapeutics Ltd (ATHE) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $66.8M; returns 1 day -2.8%, 1 week -20.2%, 1 year -54.6%.

Alterity Therapeutics Ltd (ATHE) is a clinical-stage biotechnology company headquartered in Melbourne, Australia, with operations also in San Francisco. The company is dedicated to developing disease-modifying treatments for neurodegenerative diseases, with a primary focus on Parkinsonian disorders, particularly Multiple System Atrophy (MSA).

Groups ATHE belongs to

• Clinical Stage Biotech
• Biotechnology
• Healthcare
• Neuroscience
• Neurological Disorders
• CNS Disorders
• Rare Diseases
• Clinical Stage
• Fast Track Designation
• R&D

ATHE financial model: income statement, cash flow and balance sheet